After the announcement of the 720 billion euro ($1 trillion) European Union/IMF bail out at the beginning of the week and a large relief rally after heavy falls at the end of the week before, the markets remained increasingly under pressure as the days passed. Real concerns began to surface that the eurozone may not be able to get its debt under control within slowing economic activity to a snail's pace.
The Contrarian Investor UK portfolio took the opportunity to sell positions initiated during the market weakness the week before when the eurozone bail out euphoria hit on Monday. So Coal of Africa (CZA) and Ithaca Energy (IAE) were both sold at a profit. I am now again sitting largely on the sidelines with the majority of my equity holding in GW Pharma.
GW Pharma (GWP) - Despite the volatile week on the markets, GWP's share price continued to make good progress. The shares rose over 10p or 8.7% on the week to finish at 127p as the company is due to make its interim results announcement on Thursday and an update on the regulatory approval status of multiple sclerosis drug, Sativex, is eagerly awaited. I continue to hold this a core position since it is likely that Sativex will be launched by partner Bayer Schering in June barring any regulatory set backs but this seems unlikely given the update given by the company in March.
